{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:36:16Z","timestamp":1787841376623,"version":"build-2784847793"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH106"],"award-info":[{"award-number":["ZR2020MH106"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211365"],"award-info":[{"award-number":["tsqn202211365"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170865"],"award-info":[{"award-number":["82170865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870593"],"award-info":[{"award-number":["81870593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.critrevonc.2023.103957","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T11:16:09Z","timestamp":1678533369000},"page":"103957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["NTRK fusions in thyroid cancer: Pathology and clinical aspects"],"prefix":"10.1016","volume":"184","author":[{"given":"Yanhui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzi","family":"liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangbing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxia","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-2823","authenticated-orcid":false,"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.103957_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cncy.22353","article-title":"Fine-needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology","volume":"128","author":"Abi-Raad","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabi\u00e8res","year":"2021","journal-title":"Cancer Disco"},{"key":"10.1016\/j.critrevonc.2023.103957_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40265-019-01177-y","article-title":"Entrectinib: first global approval","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103957_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO OPEN"},{"issue":"Suppl_8","key":"10.1016\/j.critrevonc.2023.103957_bib5","doi-asserted-by":"crossref","first-page":"viii5","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Anone","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2023.103957_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jmoldx.2015.10.002","article-title":"A multiplexed amplicon approach for detecting gene fusions by next-generation sequencing","volume":"18","author":"Beadling","year":"2016","journal-title":"J. Mol. Diagn.: JMD"},{"key":"10.1016\/j.critrevonc.2023.103957_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib9","first-page":"1457","article-title":"High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma","volume":"4","author":"Bongarzone","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.103957_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00000478-200007000-00005","article-title":"Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors","volume":"24","author":"Bourgeois","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathol.2021.05.100","article-title":"Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing","volume":"54","author":"Bourhis","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.critrevonc.2023.103957_bib12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAI.0000000000000933","article-title":"Fluorescent in situ hybridization must be preferred to pan-TRK immunohistochemistry to diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST)","volume":"29","author":"Castillon","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol.: AIMM"},{"key":"10.1016\/j.critrevonc.2023.103957_bib13","first-page":"2186","article-title":"Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)","volume":"33","author":"Chu","year":"2020","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-019-0542-z","article-title":"Resistance to TRK inhibition mediated by convergent MAPK pathway activation","volume":"25","author":"Cocco","year":"2019","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103957_bib16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hed.25155","article-title":"Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma","volume":"40","author":"Condello","year":"2018","journal-title":"Head. Neck"},{"key":"10.1016\/j.critrevonc.2023.103957_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e318231542a","article-title":"Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity","volume":"36","author":"Connor","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s12885-022-09559-4","article-title":"Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer","volume":"22","author":"Dadhania","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2023.103957_bib19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103957_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdw042","article-title":"What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)","volume":"27","author":"Drilon","year":"2016","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","article-title":"A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2023.103957_bib23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2023.103957_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2023.103957_bib25","first-page":"11","article-title":"Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers","author":"Eszlinger","year":"2022","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.critrevonc.2023.103957_bib26","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920975613","article-title":"A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors","volume":"12","author":"Forsythe","year":"2020","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2023.103957_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ijms23179952","article-title":"Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer","volume":"23","author":"Freitas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.103957_bib30","first-page":"147","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol., Inc."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103957_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12020-022-03004-z","article-title":"Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer","volume":"76","author":"Gouda","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.critrevonc.2023.103957_bib32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMc2023094","article-title":"Larotrectinib-enhanced radioactive iodine uptake in advanced thyroid cancer","volume":"383","author":"Groussin","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2023.103957_bib33","first-page":"12","article-title":"Molecular landscape of pediatric thyroid cancer: a review","author":"Guleria","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2023.103957_bib34","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction","volume":"72","author":"Huang","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.critrevonc.2023.103957_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","article-title":"Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2023.103957_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cncy.22413","article-title":"Building on recent cytomorphologic descriptions of NTRK-rearranged thyroid carcinoma","volume":"129","author":"Kerr","year":"2021","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103164","article-title":"FusionAI: Predicting fusion breakpoint from DNA sequence with deep learning","volume":"24","author":"Kim","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2023.103957_bib40","first-page":"5046","article-title":"ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma","volume":"58","author":"Knezevich","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.103957_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-20-1345","article-title":"NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC","volume":"184","author":"Kong","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib42","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-21-0465","article-title":"Tropomyosin receptor kinase inhibitors for the treatment of TRK fusion cancer","volume":"27","author":"Laetsch","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103957_bib43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1\/2 study. The","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib44","first-page":"131","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","author":"Lee","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2023.103957_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncy.22522","article-title":"NTRK-rearranged papillary thyroid carcinoma demonstrates frequent subtle nuclear features and indeterminate cytologic diagnoses","volume":"130","author":"Lee","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.28484","article-title":"ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer","volume":"120","author":"Leeman-Neill","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103957_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-022-01337-0","article-title":"Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer","volume":"14","author":"Li","year":"2022","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.critrevonc.2023.103957_bib48","first-page":"22","article-title":"Thyroid cancers: from surgery to current and future systemic therapies through their molecular identities","author":"Lorusso","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.103957_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/gcc.20028","article-title":"A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma","volume":"40","author":"Makretsov","year":"2004","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2023.103957_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/jpi.jpi_25_19","article-title":"Differentiating noninvasive follicular thyroid neoplasm with papillary-like nuclear features from classic papillary thyroid carcinoma: analysis of cytomorphologic descriptions using a novel machine-learning approach","volume":"10","author":"Maleki","year":"2019","journal-title":"J. Pathol. Inform."},{"key":"10.1016\/j.critrevonc.2023.103957_bib51","doi-asserted-by":"crossref","unstructured":"Manea, C.A., Badiu, D.C., Ploscaru, I.C., Zgura, A., Bacinschi, X., Smarandache, C.G., Serban, D., Popescu, C.G., Grigorean, V.T., Botnarciuc, V., 2022. A review of NTRK fusions in cancer. Annals of medicine and surgery (2012) 79, 103893.","DOI":"10.1016\/j.amsu.2022.103893"},{"key":"10.1016\/j.critrevonc.2023.103957_bib52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152572","article-title":"NTRK-Fusions - A new kid on the block","volume":"215","author":"M\u00e4rkl","year":"2019","journal-title":"Pathol., Res. Pract."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103957_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41416-022-01769-8","article-title":"Liquid biopsies to monitor and direct cancer treatment in colorectal cancer","volume":"127","author":"Mauri","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.103957_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canep.2018.05.009","article-title":"Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980-2014","volume":"55","author":"Mirian","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cncy.21199","article-title":"Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration","volume":"120","author":"Monaco","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib57","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1158\/1078-0432.CCR-20-1630","article-title":"U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b\/AB-106), a ROS1\/TRK inhibitor, in patients with advanced solid tumors","volume":"26","author":"Papadopoulos","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103957_bib58","article-title":"Real-World experience of NTRK fusion-positive thyroid cancer","volume":"6","author":"Park","year":"2022","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib59","doi-asserted-by":"crossref","first-page":"8909224","DOI":"10.1155\/2021\/8909224","article-title":"Detection of circulating tumor DNA in patients with thyroid nodules","volume":"2021","author":"Patel","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib60","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2023.103957_bib61","first-page":"13","article-title":"NTRK fusion genes in thyroid carcinomas: clinicopathological characteristics and their impacts on prognosis","author":"Pekova","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103957_bib62","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2589-7500(21)00041-8","article-title":"Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study","volume":"3","author":"Peng","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.critrevonc.2023.103957_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2350\/15-07-1667-OA.1","article-title":"Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA\/RNA ThyroSeq v2 next-generation sequencing assay","volume":"19","author":"Picarsic","year":"2016","journal-title":"Pediatr. Dev. Pathol. Off. J. Soc. Pediatr. Pathol. Paediatr. Pathol. Soc."},{"key":"10.1016\/j.critrevonc.2023.103957_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.29887","article-title":"NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States","volume":"122","author":"Prasad","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2023.103957_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib66","first-page":"20","article-title":"Extracellular vesicles from thyroid carcinoma: the new frontier of liquid biopsy","author":"Rappa","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.103957_bib67","first-page":"22","article-title":"Novel inhibitor-based therapies for thyroid cancer-an update","author":"Ratajczak","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.103957_bib68","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1172\/JCI69766","article-title":"Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers","volume":"123","author":"Ricarte-Filho","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2023.103957_bib69","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(20)30026-7","article-title":"NTRK gene fusions: a rough diamond ready to sparkle","volume":"21","author":"Rolfo","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib70","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1078-0432.CCR-19-3165","article-title":"TRK fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations","volume":"26","author":"Rosen","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103957_bib71","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk IMmunohistochemistry Identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/2159-8290.CD-15-0940","article-title":"Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer","volume":"6","author":"Russo","year":"2016","journal-title":"Cancer Disco"},{"key":"10.1016\/j.critrevonc.2023.103957_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40265-018-1044-x","article-title":"Larotrectinib: first global approval","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.critrevonc.2023.103957_bib74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/PAS.0000000000000814","article-title":"Clinical and morphologic features of ETV6-NTRK3 translocated papillary thyroid carcinoma in an adult population without radiation exposure","volume":"41","author":"Seethala","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/3H24-E7T7-V37G-AKKQ","article-title":"Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues","volume":"115","author":"Sheng","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib76","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-19-0372","article-title":"Detection of NTRK fusions: merits and limitations of current diagnostic platforms","volume":"79","author":"Solomon","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.103957_bib77","doi-asserted-by":"crossref","first-page":"viii16","DOI":"10.1093\/annonc\/mdz384","article-title":"Identifying patients with NTRK fusion cancer","volume":"30","author":"Solomon","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib78","first-page":"38","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol., Inc."},{"key":"10.1016\/j.critrevonc.2023.103957_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00292-020-00864-y","article-title":"Diagnosis and therapy of tumors with NTRK gene fusion","volume":"42","author":"Stenzinger","year":"2021","journal-title":"Der Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/healthcare9040386","article-title":"Limited clinical and diagnostic utility of circulating tumor DNA detection in patients with early-stage well-differentiated thyroid cancer: comparison with benign thyroid nodules and healthy individuals","volume":"9","author":"Suh","year":"2021","journal-title":"Healthcare"},{"key":"10.1016\/j.critrevonc.2023.103957_bib81","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103957_bib82","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/thy.2019.0752","article-title":"AIBx, artificial intelligence model to risk stratify thyroid nodules","volume":"30","author":"Thomas","year":"2020","journal-title":"Thyroid Off. J. Am. Thyroid. Assoc."},{"key":"10.1016\/j.critrevonc.2023.103957_bib83","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2023.103957_bib84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clon.2017.02.009","article-title":"Targeted therapy in thyroid cancer: state of the art","volume":"29","author":"Valerio","year":"2017","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib85","first-page":"105","article-title":"Is thyroid cancer increasing in incidence and aggressiveness","author":"Vigneri","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2023.103957_bib86","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncy.22374","article-title":"Cytomorphologic features of NTRK-rearranged thyroid carcinoma","volume":"128","author":"Viswanathan","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib87","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-21-1259","article-title":"Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma","volume":"186","author":"Waguespack","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib88","article-title":"Larotrectinib before initial radioactive iodine therapy in pediatric TRK fusion-positive papillary thyroid carcinoma: time to reconsider the treatment paradigm for distantly metastatic disease","volume":"6","author":"Waguespack","year":"2022","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2021.03.007","article-title":"NTRK fusions and Trk proteins: what are they and how to test for them","volume":"112","author":"Weiss","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2023.103957_bib90","first-page":"13","article-title":"Translational utility of liquid biopsies in thyroid cancer management","author":"Wijewardene","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.103957_bib91","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/acs.jmedchem.8b01092","article-title":"Insights into current tropomyosin receptor kinase (TRK) inhibitors: development and clinical application","volume":"62","author":"Yan","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2023.103957_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242806","article-title":"Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer","volume":"15","author":"Yoon","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103957_bib93","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/s41467-020-18497-3","article-title":"Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2023.103957_bib94","first-page":"1","article-title":"NTRK fusions identified in pediatric tumors: the frequency, fusion partners, and clinical outcome","author":"Zhao","year":"2021","journal-title":"JCO Precis Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:37:17Z","timestamp":1778794637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":94,"alternative-id":["S1040842823000458"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103957","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NTRK fusions in thyroid cancer: Pathology and clinical aspects","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103957"}}